Literature DB >> 8134134

Inducible regulatory elements in the human cyclin D1 promoter.

B Herber1, M Truss, M Beato, R Müller.   

Abstract

To be able to elucidate the function of cyclin D1 in the control of cell cycle progression and its role as an oncogene in tumorigenesis, it is of paramount importance to understand the mechanisms involved in the regulation of its expression. In the present study, we have cloned the human cyclin D1 gene and analysed the structure and function of 3kb of its 5'-flanking region. Several regulatory regions involved in both basal level and serum-induced expression were identified, two of which turned out to be of particular interest. One of these regions is involved in serum induction and is located 848-944 bp upstream of the initiation site. In agreement with this result, in vivo footprinting revealed a novel, strongly inducible protein binding site around positions -928 to -921. A second constitutively occupied binding site was mapped to a potential CRE at position -52. Cotransfection experiments showed that the cyclin D1 promoter is inducible by c-Jun, and that this induction is mediated predominantly through the protected putative CRE at -52.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8134134

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  73 in total

1.  NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

Authors:  D C Guttridge; C Albanese; J Y Reuther; R G Pestell; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 2.  Molecular link between cholesterol, cytokines and atherosclerosis.

Authors:  D Kaul
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

3.  Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription.

Authors:  Wei-Ming Wang; Shwu-Yuan Wu; A-Young Lee; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

4.  Growth-inhibitory effect of cyclic GMP- and cyclic AMP-dependent vasodilators on rat vascular smooth muscle cells: effect on cell cycle and cyclin expression.

Authors:  N Kronemann; W A Nockher; R Busse; V B Schini-Kerth
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

5.  Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer.

Authors:  Yoku Hayakawa; Yoshihiro Hirata; Hayato Nakagawa; Kei Sakamoto; Yohko Hikiba; Hiroto Kinoshita; Wachiko Nakata; Ryota Takahashi; Keisuke Tateishi; Motohisa Tada; Masao Akanuma; Haruhiko Yoshida; Kohsuke Takeda; Hidenori Ichijo; Masao Omata; Shin Maeda; Kazuhiko Koike
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

6.  An alternative pathway for gene regulation by Myc.

Authors:  K Peukert; P Staller; A Schneider; G Carmichael; F Hänel; M Eilers
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

7.  The spot 14 protein inhibits growth and induces differentiation and cell death of human MCF-7 breast cancer cells.

Authors:  Jinny Sanchez-Rodriguez; John P Kaninda-Tshilumbu; Angel Santos; Ana Perez-Castillo
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

8.  JunB breakdown in mid-/late G2 is required for down-regulation of cyclin A2 levels and proper mitosis.

Authors:  Rosa Farràs; Véronique Baldin; Sandra Gallach; Claire Acquaviva; Guillaume Bossis; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2008-04-07       Impact factor: 4.272

9.  Fos family members induce cell cycle entry by activating cyclin D1.

Authors:  J R Brown; E Nigh; R J Lee; H Ye; M A Thompson; F Saudou; R G Pestell; M E Greenberg
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Transcriptional activity of c-Jun is critical for the suppression of AR function.

Authors:  Chih-Chao Hsu; Chang-Deng Hu
Journal:  Mol Cell Endocrinol       Date:  2013-03-21       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.